Finds higher target hemoglobin levels increase risk without quality-of-life benefits in chronic kidney disease, highlighting the dangers of complete anemia correction.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Singh et al. (2006) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: